New Edge Advisors, LLC Innoviva, Inc. Transaction History

New Edge Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$14.56 - $16.78 $12,798 - $14,749	-879 Reduced 53.02%	779 $11,000
Q4 2023 Feb 13, 2024	BUY	$12.32 - $16.27 $20,426 - $26,975	1,658 New	1,658 $26,000
Q4 2022 Feb 14, 2023	BUY	$11.8 - $13.78 $3,351 - $3,913	284 New	284 $3,000
Q3 2017 Nov 13, 2017	SELL	$12.06 - $14.12 $15,678 - $18,356	-1,300 Closed	0 $0
Q2 2017 Aug 16, 2017	BUY	N/A	1,300	1,300 $0

229

79.2M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.33B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on New Edge Advisors, LLC with notifications on news.